Transradial Access Market - Forecast(2024 - 2030)

Report Code: HCR 13996 Report Format: PDF + Excel

Transradial Access Market Overview

Transradial Access Market size is forecast to reach $2.7 billion by 2026, growing at a CAGR of 7.8% during the forecast period 2021-2026. Transradial access devices are extensively used in coronary procedures like angiograms to lower complications. These devices can also treat peripheral lesions and cardiogenic shock by doing hyperalimentation. Transradial access devices like catheters and guidewires are used for peripheral artery diseases like atherosclerosis diseases of abdominal mesenteric, renal, and extremity arteries, as well as extracranial carotid and vertebral arteries. The growing prevalence of obesity, rising inclination of consumers towards interventional procedures using radial artery access, advancements in technology, a growing number of lifestyle diseases, and rising abundance of chemotherapy procedures worldwide are the major factors propelling the growth of the market. Transradial access minimizes bleeding risks by over 70% even among the high-risk groups which is set to further enhance the overall market developments of the Transradial Access Market for the period 2021-2026.

Report Coverage

The report: Transradial Access Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Transradial Access Market.

By Product Type: Catheters, Guidewires, Sheaths, and Sheath Introducers, and Accessories.
By Application: Drug Administration, Fluid And Nutrition Administration, Blood Transfusion, and Diagnostics and Testing
By End-User: Hospitals, Clinics, and Ambulatory Care Centres, and Others.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa).

Key Takeaways

  • North America dominated the Transradial Access Market in 2020 owing to the rising incidence of cardiovascular diseases mainly from obesity and the rapidly growing urban lifestyle. The Transradial Access Market scope for different regions will be provided in the final report.
  • Growing prevalence of cardiovascular diseases due to lifestyle-related diseases coupled with the rising inclination towards interventional procedures using radial artery access is likely to aid the market growth of the Transradial Access Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be Transradial Access Market report.
  • Higher costs involved in the placement and maintenance of vascular access devices is poised to create hurdles for the Transradial Access Market.


Transradial Access Market Segment Analysis – Geographical data

Transradial Access Market Segment Analysis – Geographical data

For More Details on This Report - Request for Sample

Transradial Access Market Segment Analysis – By Product Type

The Catheters segment held the largest share in the Transradial Access Market in 2020 and is estimated to grow at a CAGR of 7.3% during the forecast period 2021-2026. This is owing to the growing prevalence of lifestyle-related diseases like cardiovascular diseases, obesity, and diabetes coupled with the rising incidence of interventional and angiography procedures. A catheter is a soft hollow tube, necessary for people with various health conditions, to drain urine from the bladder. Catheters are utilized extensively in hospitals as well as patients who are under supervision residentially, which is propelling the growth of the market. However, the usage of guidewires is also gaining traction owing to its extensive usage to gain access to the blood vessel using the less complicated invasive technique, which is likely to augment the growth of this segment. Guidewires segment is estimated to register the higher CAGR over the period 2021-2026.

Transradial Access Market Segment Analysis – By Application

The drug administration segment held the largest share in the Transradial Access Market in 2020 and is estimated to grow at a CAGR of 7.0% during the forecast period 2021-2026. This is owing to the growing usage of transradial access devices over other conventional devices especially for the treatment of diseases like cerebrovascular disease, coronary heart disease, rheumatic heart disease, and life-threatening diseases like cancer. Additionally, the growing incidence of chronic diseases worldwide is another factor bolstering the growth of this segment. However, with the growing incidence of consumers focusing on health and wellness, the need to keep track of bodily fluids is becoming a concern, which is likely to bolster the growth of this segment. The fluid and Nutrition Administration segment is estimated to register the higher CAGR over the period 2021-2026.

Transradial Access Market Segment Analysis – By Geography

North America dominated the Transradial Access Market with a major share of 37.8% in 2020. This is attributed to the factors like the growing incidence of cardiovascular diseases mainly from obesity and rapidly growing urban lifestyle, a growing number of conferences and workshops, the substantial base of cancer patients, and growth in research and clinical trials for vascular access devices, in the recent past. All these factors are likely to bolster the market growth of transradial devices of all types catering to different applications, in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to a large number of patients suffering from cardiovascular diseases in this region, where the population has been increasing exponentially for decades. Additionally, countries like China and Japan have been progressively evolving on the technology front, which is augmenting the growth of the market in this region.

Transradial Access Market Drivers

Growing prevalence of cardiovascular diseases due to lifestyle-related diseases are driving the market growth

Over the recent past, the growing incidence of obesity leading to cardiovascular diseases are augmenting the market growth. Obesity coupled with improper diet leads to diabetes among the population. The lack of exercise due to rapid urbanization and busy lifestyle coupled with unhealthy diets, specifically containing trans fatty acids increases the risk for the development of obesity leading to disorders of the heart in the form of coronary heart disease, and rheumatic heart disease, among others. According to the Centers for Disease Control and Prevention (CDC), 1 person dies every 36 seconds in the U.S. from cardiovascular disease and roughly 655,000 Americans died from heart disease in 2020 —that’s 1 in every 4 deaths. According to European Heart Network, a rough of about 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU) has been recorded in 2020, only from cardiovascular diseases. Hence, the usage of transradial devices in all its types becomes very prominent not only in North America but also across all the major economies. Thus, increasing the growth of the Transradial Access Market during the forecast period 2021-2026. 

Rising inclination towards interventional procedures using radial artery access is poised to increase the growth of the market

The growing preference towards interventional procedures with the help of radial artery access is bolstering the market growth. Radial access for cardiac catheterization and intervention is preferred in developing nations. According to a survey by the American Journal of Roentgenology, 8.5–11.5% of radiologists are interventionalists and they spend 70% or more of their clinical work time performing interventional procedures. Different procedures like radiation exposure to femoral procedures, the potential to conduct complex coronary interventions, initial ambulation, and patient preference is rising. The main advantage of using transradial devices is instant ambulation, which is usually proceeded by complete bed rest post femoral procedures. The cost of transradial when compared to femoral is lower, which needs fewer post procedures for nursing care, and it has reduced hospital stay and cost. Thus, increasing the growth of the Transradial Access Market during the forecast period 2021-2026.

Transradial Access Market Challenges

Higher costs involved in the placement and maintenance of vascular access devices is likely to challenge the market growth

Some of the factors that is set to impede the growth of the Transradial Access Market are the stringent regulatory scenarios, low reimbursements, and high cost of procedures. Transradial devices when arranged and used over a considerable period of time becomes expensive to maintain. According to Medical University of South Carolina (MUSC), Diagnosis-related group (DRG) reimbursements for inpatient and outpatient rates vary from about $10,000 for inpatients and $7,500 for outpatient, which is primarily due to the fact that 60% of the treatments are done using transradial access.

Transradial Access Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Transradial Access Market. In 2020, the Transradial Access Market share is fragmented by the top ten players present in the market. The Transradial Access Market, top 10 companies are:

  • Ameco Medical
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Edward Lifesciences Corporation
  • Terumo Corporation
  • Teleflex Incorporated
  • Smiths Medical
  • Nipro Medical Corporation
  • Merit Medical Systems
  • Medtronic plc

 Recent Developments:

  • In August 2021, Medtronic plc entered into a definitive agreement with Intersect ENT, a global ear, nose, and throat (ENT) medical technology company, in which Medtronic will acquire all outstanding shares of Intersect ENT for USD 28.25 per share in an all-cash transaction implying an enterprise value of approximately USD 1.1 billion.
  • In March 2021, Boston Scientific acquired Israeli Medtech Lumenis’s surgical portfolio in a GBP 1.07 billion the cash deal, which is its second major acquisition of 2021.

Relevant Titles:

Wearable Medical Devices Market: Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2021 - 2026
Report Code: FBR 0015

Medical Alert Systems Market: Forecast (2021 - 2026)
Report Code: FBR 0008

For more Lifesciences and Healthcare related reports, please click here

1. Transradial Access Market- Overview
    1.1 Definitions and Scope
2. Transradial Access Market- Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Application
    2.4 Key trends by End User
3. Transradial Access Market– Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Transradial Access Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Transradial Access Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Transradial Access Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Transradial Access Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Transradial Access Market– By Product Type(Market Size –$Million/$Billion)
    8.1 Catheters
    8.2 Guidewires
    8.3 Sheaths and Sheath Introducers
    8.4 Accessories
9. Transradial Access Market– By Application(Market Size –$Million/$Billion)
    9.1 Drug Administration
    9.2 Fluid and Nutrition Administration
    9.3 Blood Transfusion
    9.4 Diagnostics and Testing
10. Transradial Access Market– By End User(Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Clinics and Ambulatory Care Centres
    10.3 Others
11. Transradial Access Market- By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Transradial Access Market- Entropy
13. Transradial Access Market– Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Competition Matrix
        13.1.5 Best Practices for Companies
14. Transradial Access Market– Key Company List by Country Premium Premium
15. Transradial Access Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Transradial Access Device Market, By Product Market 2023-2030 ($M)
1.1 Catheter Market 2023-2030 ($M) - Global Industry Research
1.2 Guidewires Market 2023-2030 ($M) - Global Industry Research
1.3 Sheath And Sheath Introducers Market 2023-2030 ($M) - Global Industry Research
1.4 Accessory Market 2023-2030 ($M) - Global Industry Research
2.Global Transradial Access Device Market, By End User Market 2023-2030 ($M)
2.1 Hospital Market 2023-2030 ($M) - Global Industry Research
2.2 Clinic And Ambulatory Care Center Market 2023-2030 ($M) - Global Industry Research
3.Global Transradial Access Device Market, By Product Market 2023-2030 (Volume/Units)
3.1 Catheter Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Guidewires Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Sheath And Sheath Introducers Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Accessory Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Transradial Access Device Market, By End User Market 2023-2030 (Volume/Units)
4.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Clinic And Ambulatory Care Center Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Transradial Access Device Market, By Product Market 2023-2030 ($M)
5.1 Catheter Market 2023-2030 ($M) - Regional Industry Research
5.2 Guidewires Market 2023-2030 ($M) - Regional Industry Research
5.3 Sheath And Sheath Introducers Market 2023-2030 ($M) - Regional Industry Research
5.4 Accessory Market 2023-2030 ($M) - Regional Industry Research
6.North America Transradial Access Device Market, By End User Market 2023-2030 ($M)
6.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
6.2 Clinic And Ambulatory Care Center Market 2023-2030 ($M) - Regional Industry Research
7.South America Transradial Access Device Market, By Product Market 2023-2030 ($M)
7.1 Catheter Market 2023-2030 ($M) - Regional Industry Research
7.2 Guidewires Market 2023-2030 ($M) - Regional Industry Research
7.3 Sheath And Sheath Introducers Market 2023-2030 ($M) - Regional Industry Research
7.4 Accessory Market 2023-2030 ($M) - Regional Industry Research
8.South America Transradial Access Device Market, By End User Market 2023-2030 ($M)
8.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
8.2 Clinic And Ambulatory Care Center Market 2023-2030 ($M) - Regional Industry Research
9.Europe Transradial Access Device Market, By Product Market 2023-2030 ($M)
9.1 Catheter Market 2023-2030 ($M) - Regional Industry Research
9.2 Guidewires Market 2023-2030 ($M) - Regional Industry Research
9.3 Sheath And Sheath Introducers Market 2023-2030 ($M) - Regional Industry Research
9.4 Accessory Market 2023-2030 ($M) - Regional Industry Research
10.Europe Transradial Access Device Market, By End User Market 2023-2030 ($M)
10.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
10.2 Clinic And Ambulatory Care Center Market 2023-2030 ($M) - Regional Industry Research
11.APAC Transradial Access Device Market, By Product Market 2023-2030 ($M)
11.1 Catheter Market 2023-2030 ($M) - Regional Industry Research
11.2 Guidewires Market 2023-2030 ($M) - Regional Industry Research
11.3 Sheath And Sheath Introducers Market 2023-2030 ($M) - Regional Industry Research
11.4 Accessory Market 2023-2030 ($M) - Regional Industry Research
12.APAC Transradial Access Device Market, By End User Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Clinic And Ambulatory Care Center Market 2023-2030 ($M) - Regional Industry Research
13.MENA Transradial Access Device Market, By Product Market 2023-2030 ($M)
13.1 Catheter Market 2023-2030 ($M) - Regional Industry Research
13.2 Guidewires Market 2023-2030 ($M) - Regional Industry Research
13.3 Sheath And Sheath Introducers Market 2023-2030 ($M) - Regional Industry Research
13.4 Accessory Market 2023-2030 ($M) - Regional Industry Research
14.MENA Transradial Access Device Market, By End User Market 2023-2030 ($M)
14.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
14.2 Clinic And Ambulatory Care Center Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Transradial Access Market Revenue, 2023-2030 ($M)
2.Canada Transradial Access Market Revenue, 2023-2030 ($M)
3.Mexico Transradial Access Market Revenue, 2023-2030 ($M)
4.Brazil Transradial Access Market Revenue, 2023-2030 ($M)
5.Argentina Transradial Access Market Revenue, 2023-2030 ($M)
6.Peru Transradial Access Market Revenue, 2023-2030 ($M)
7.Colombia Transradial Access Market Revenue, 2023-2030 ($M)
8.Chile Transradial Access Market Revenue, 2023-2030 ($M)
9.Rest of South America Transradial Access Market Revenue, 2023-2030 ($M)
10.UK Transradial Access Market Revenue, 2023-2030 ($M)
11.Germany Transradial Access Market Revenue, 2023-2030 ($M)
12.France Transradial Access Market Revenue, 2023-2030 ($M)
13.Italy Transradial Access Market Revenue, 2023-2030 ($M)
14.Spain Transradial Access Market Revenue, 2023-2030 ($M)
15.Rest of Europe Transradial Access Market Revenue, 2023-2030 ($M)
16.China Transradial Access Market Revenue, 2023-2030 ($M)
17.India Transradial Access Market Revenue, 2023-2030 ($M)
18.Japan Transradial Access Market Revenue, 2023-2030 ($M)
19.South Korea Transradial Access Market Revenue, 2023-2030 ($M)
20.South Africa Transradial Access Market Revenue, 2023-2030 ($M)
21.North America Transradial Access By Application
22.South America Transradial Access By Application
23.Europe Transradial Access By Application
24.APAC Transradial Access By Application
25.MENA Transradial Access By Application
26.Becton, Dickinson And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Terumo Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Teleflex Incorporated, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Smith Medical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Medtronic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Edward Lifesciences Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Merit Medical System, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Boston Scientific Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Nipro Medical Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Angiodynamics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Ameco Medical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Oscor Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)